Page 5 - Drug Controller General Of India

Glenmark gets DCGI nod for clinical trials of potential Covid-19 drug

As per the clinical trial protocol approved, 150 subjects with mild to moderate Covid-19 will be randomised in the study in a 1:1 ratio to Favipiravir with standard supportive care

Covid-19 treatment: AIIMS to conduct clinical trials of plasma therapy

The AIIMS director stresses on the need to have good and well-conducted research trials before the therapy is recommended for routine use

Govt sanctions Rs 1,850 cr to ensure better drug monitoring systems

A significant share of this money will go into upgrading the Sugam portal - the e-governance solution for CDSCO.

Drug controller cracks whip on e-pharmacies selling drugs without licences

Last December the Delhi High Court had said online sale of medicines without a licence was injuncted, and had instructed the government to ensure that the same was prohibited forthwith

GSK suspends sale of antacid Zinetac after USFDA issues advisory

Indian drugmakers have also started testing their ranitidine products at various laboratories after the US FDA issued an advisory on the drug to health care professionals

Submit licence application data within 45 days: DCGI

If the companies do not submit such information within 45 days, the DCGI would dispose of such application with the incomplete data